Although optimal tumoricidal activity may typically occur when tumor responses involve both CD4 and CD8 T cells [38], CD4 T cells by themselves can provide powerful tumor immunity often exceeding that provided by CD8 T cells even when tumors fail to express major histocompatibility complex (MHC) class II molecules [39]. The gene discussed is CD8A; the disease is neoplasm.